Skip to main content

Table 3 HRs of all-cause, CVD and cancer-related mortality among different T2D subgroups

From: An affordable approach to classifying type 2 diabetes based on fasting plasma glucose, TyG index and BMI: a retrospective cohort study of NHANES Data from 1988 to 2014

 

Subgroup A

Subgroup B

Subgroup C

Subgroup D

All-cause mortality (n = 4043)

 Model 1a

1.00

1.23 (0.97,1.55) 0.087

1.54 (1.16,2.03) 0.002

1.60 (0.96,2.66) 0.073

 Model 2b

1.00

1.19 (0.93,1.52) 0.158

1.51 (1.14,1.99) 0.004

1.49 (0.86,2.58) 0.157

 Model 3c

1.00

1.30 (1.02,1.67) 0.036

1.48 (1.06,2.06) 0.022

1.46 (0.85,2.52) 0.169

CVD (n = 4043)

 Model 1a

1.00

0.93 (0.60,1.45) 0.747

1.57 (0.92,2.69) 0.097

1.13 (0.13,10.15) 0.910

 Model 2b

1.00

0.91 (0.57,1.44) 0.688

1.54 (0.88,2.68) 0.127

1.06 (0.10,10.73) 0.962

 Model 3c

1.00

1.04 (0.68,1.62) 0.846

1.19 (0.62,2.27) 0.604

0.90 (0.09,9.00) 0.929

Cancer (n = 4043)

 Model 1a

1.00

1.03 (0.55,1.96) 0.920

1.19 (0.51,2.78) 0.687

0.69 (0.09,5.15) 0.718

 Model 2b

1.00

1.02 (0.54,1.92) 0.952

1.14 (0.48,2.67) 0.768

0.66 (0.08,5.19) 0.696

 Model 3c

1.00

1.11 (0.55,2.24) 0.774

1.43 (0.48,4.25) 0.517

0.76 (0.07,8.02) 0.816

  1. aModel 1: adjusted for age, sex and race/ethnicity
  2. bModel 2: further adjusted (from Model 1) for education level, family income-poverty ratio, smoking status, ideal physical activity
  3. cModel 3: further adjusted (from Model 2) for duration of diabetes, diabetes medication use, self-reported hypertension, hypercholesterolemia, and CVD, hypertriglyceridemia, self-reported hypertension, hypercholesterolemia medication use, systolic blood pressure, diastolic blood pressure, total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol